Literature DB >> 8545499

Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia.

T Kato1, T Shioiri, J Murashita, H Hamakawa, T Inubushi, S Takahashi.   

Abstract

Magnetic resonance spectroscopy (one-dimensional chemical shift imaging) was used to measure membrane phospholipid metabolism and high-energy phosphate metabolism in the left and right frontal lobes of 27 schizophrenic patients. In the schizophrenic patients, the phosphomonoester peak area was decreased in bilateral frontal lobes compared with that in age-matched normal subjects. On the other hand, the peak area of beta-adenosine triphosphate was increased in the left frontal lobe in the schizophrenic group. The phosphocreatine peak area was increased in the left frontal lobe of schizophrenic patients with high scores on the Scale for the Assessment of Negative Symptoms (SANS).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8545499     DOI: 10.1016/0925-4927(95)02752-j

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  10 in total

1.  Neuropil pruning in Early-Course Schizophrenia: Immunological, Clinical, and Neurocognitive Correlates.

Authors:  Konasale M Prasad; Ashley M Burgess; Matcheri S Keshavan; Vishwajit L Nimgaonkar; Jeffrey A Stanley
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-11

Review 2.  Genetically mediated brain abnormalities in schizophrenia.

Authors:  Larry J Seidman; Heidi E Wencel
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

3.  Impaired metabolic reactivity to oxidative stress in early psychosis patients.

Authors:  Margot Fournier; Carina Ferrari; Philipp S Baumann; Andrea Polari; Aline Monin; Tanja Bellier-Teichmann; Jacob Wulff; Kirk L Pappan; Michel Cuenod; Philippe Conus; Kim Q Do
Journal:  Schizophr Bull       Date:  2014-03-31       Impact factor: 9.306

4.  Abnormal high-energy phosphate molecule metabolism during regional brain activation in patients with bipolar disorder.

Authors:  C Yuksel; F Du; C Ravichandran; J R Goldbach; T Thida; P Lin; B Dora; J Gelda; L O'Connor; S Sehovic; S Gruber; D Ongur; B M Cohen
Journal:  Mol Psychiatry       Date:  2015-03-10       Impact factor: 15.992

Review 5.  The bimodal mechanism of interaction between dopamine and mitochondria as reflected in Parkinson's disease and in schizophrenia.

Authors:  Dorit Ben-Shachar
Journal:  J Neural Transm (Vienna)       Date:  2019-12-17       Impact factor: 3.575

6.  Regionally Distinct Alterations in Membrane Phospholipid Metabolism in Schizophrenia: A Meta-analysis of Phosphorus Magnetic Resonance Spectroscopy Studies.

Authors:  Connor S Haszto; Jeffrey A Stanley; Satish Iyengar; Konasale M Prasad
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-10-01

Review 7.  Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?

Authors:  Patricia J Allen
Journal:  Neurosci Biobehav Rev       Date:  2012-03-24       Impact factor: 8.989

8.  Brain lactate and pH in schizophrenia and bipolar disorder: a systematic review of findings from magnetic resonance studies.

Authors:  Asli Ercan Dogan; Cagri Yuksel; Fei Du; Virginie-Anne Chouinard; Dost Öngür
Journal:  Neuropsychopharmacology       Date:  2018-03-14       Impact factor: 7.853

Review 9.  The Neurobiology of Depression: an Integrated Overview from Biological Theories to Clinical Evidence.

Authors:  F Ferrari; R F Villa
Journal:  Mol Neurobiol       Date:  2016-08-10       Impact factor: 5.590

Review 10.  Psychosis related to neurological conditions: pro and cons of the dis- / mis-connectivity models of schizophrenia.

Authors:  Jack R Foucher; David Luck
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.